These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6147471)

  • 1. Prophylaxis of Pneumocystis carinii infection in AIDS with pyrimethamine-sulfadoxine.
    Gottlieb MS; Knight S; Mitsuyasu R; Weisman J; Roth M; Young LS
    Lancet; 1984 Aug; 2(8399):398-9. PubMed ID: 6147471
    [No Abstract]   [Full Text] [Related]  

  • 2. Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndrome.
    Fischl MA; Dickinson GM
    Ann Intern Med; 1986 Oct; 105(4):629. PubMed ID: 3489429
    [No Abstract]   [Full Text] [Related]  

  • 3. Fansidar and Pneumocystis carinii pneumonia.
    Frissen PH; Stronkhorst A; Eeftinck Schattenkerk JK; Danner SA
    Ann Intern Med; 1988 Apr; 108(4):638-9. PubMed ID: 3258139
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.
    Pearson RD; Hewlett EL
    Ann Intern Med; 1987 May; 106(5):714-8. PubMed ID: 3551713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fansidar--a treatment for AIDS-related pneumocystis?
    Bath PM; Lillicrap DA; Winter M
    Postgrad Med J; 1987 Jun; 63(740):509-10. PubMed ID: 3501583
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse reactions associated with pyrimethamine-sulfadoxine prophylaxis for Pneumocystis carinii infections in AIDS.
    Navin TR; Miller KD; Satriale RF; Lobel HO
    Lancet; 1985 Jun; 1(8441):1332. PubMed ID: 2860516
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of Pneumocystis carinii pneumonia.
    Med Lett Drugs Ther; 1988 Oct; 30(776):94-5. PubMed ID: 3050408
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy and prophylaxis of Pneumocystis carinii pneumonia.
    Dutz W; Post C; Jennings-Khodadad E; Fakouhi T; Kohout E; Bandarizadeh B
    Natl Cancer Inst Monogr; 1976 Oct; 43():179-85. PubMed ID: 828241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person.
    Raviglione MC; Dinan WA; Pablos-Mendez A; Palagiano A; Sabatini MT
    Arch Intern Med; 1988 Dec; 148(12):2683-5. PubMed ID: 3264143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrimethamine/sulfadoxine for prevention of Pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus.
    Jurado R; Garcia-Herola A; Garcia-Lazaro M; Kindelan JM; Villanueva JL; Torre-Cisneros J
    Clin Infect Dis; 1994 Jul; 19(1):218-9. PubMed ID: 7948546
    [No Abstract]   [Full Text] [Related]  

  • 11. Fansidar-associated fatal reaction in an HIV-infected man.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Sep; 37(37):571-2, 577. PubMed ID: 3137443
    [No Abstract]   [Full Text] [Related]  

  • 12. Pneumocystis carinii pneumonia: therapy and prophylaxis.
    Kovacs JA; Masur H
    J Infect Dis; 1988 Jul; 158(1):254-9. PubMed ID: 2969023
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pyrimethamine and sulfadoxine as a preventive treatment for Pneumocystis carinii and Toxoplasma encephalitis].
    Teira R; Virosta M; Baraia-Etxaburu J; Muñoz J; Zubero Z; Cisterna R; Santamaría JM
    Enferm Infecc Microbiol Clin; 1999; 17(7):347-9. PubMed ID: 10535188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of pyrimethamine/sulfadoxine for prevention of Pneumocystis carinii pneumonia in patients with AIDS.
    Bessesen MT; Miller LA; Cohn DL; Bartlett S; Ellison RT
    Clin Infect Dis; 1995 Mar; 20(3):730-1. PubMed ID: 7756514
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation.
    Torre-Cisneros J; De la Mata M; Pozo JC; Serrano P; Briceño J; Solórzano G; Miño G; Pera C; Sánchez-Guijo P
    Clin Infect Dis; 1999 Oct; 29(4):771-4. PubMed ID: 10589886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis and treatment of Pneumocystis carinii pneumonia.
    O'Doherty MJ; Bateman NT
    Br J Hosp Med; 1991 May; 45(5):277-8, 280, 283. PubMed ID: 1676607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
    Hardy WD
    AIDS Clin Rev; 1991; ():145-80. PubMed ID: 1651099
    [No Abstract]   [Full Text] [Related]  

  • 18. Leads from the MMWR. Fansidar-associated fatal reaction in an HIV-infected man.
    JAMA; 1988 Oct; 260(15):2193. PubMed ID: 3262778
    [No Abstract]   [Full Text] [Related]  

  • 19. Experience with pneumocystis carinii pneumonia in patients with AIDS.
    Ingram RJ; Davis R; Ellis-Pegler RB
    N Z Med J; 1989 Sep; 102(876):496-8. PubMed ID: 2797573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients.
    Ruf B; Schürmann D; Bergmann F; Schüler-Maué W; Grünewald T; Gottschalk HJ; Witt H; Pohle HD
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):325-9. PubMed ID: 8354297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.